Report: Drug-device combo market is poised for robust growth

12/26/2013 | Medical Device & Diagnostic Industry online

A Transparency Market Research report forecasts that the worldwide market for drug-device combination products such as drug-eluting stents, bone grafts and infusion pumps will increase from $66 billion in 2012 to $115.1 billion by 2019. Growth will be driven in part by the rising number of chronic obstructive pulmonary disease, asthma and cardiovascular disease cases, the report notes.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD